Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.4B | 4.7B | 5.3B | 5.4B |
Cost of revenue | 2.7B | 2.7B | 2.9B | 2.6B |
Gross profit | 1.7B | 2.1B | 2.4B | 2.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 802.5M | 708.2M | 872.8M | 828.9M |
Other operating expenses | — | — | — | — |
Operating income | 731.3M | 1.2B | 1.4B | 1.9B |
Non operating interest income | ||||
Income | 970.2M | 1.1B | 1.1B | 997.2M |
Expense | 432.2M | 449.8M | 477.8M | 440.2M |
Other income expense | — | — | — | — |
Pretax income | 1.6B | 2.5B | 2.6B | 2.5B |
Tax provision | 352.5M | 528.6M | 582.4M | 653.6M |
Net income | 1.3B | 2.0B | 2.1B | 1.8B |
Basic EPS | — | 6.4 | 6.7 | 5.9 |
Diluted EPS | — | 6.1 | 6.4 | 5.8 |
Basic average shares | — | 308.5M | 307.4M | 306.7M |
Diluted average shares | — | 325.3M | 320.4M | 315.8M |
EBITDA | 2.2B | 3.1B | 3.2B | 3.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | -719K | -942K | -2.8M | -937K |
Preferred stock dividends | 0 | 0 | 0 | 0 |